FDA approves drug that can slow early-stage Alzheimer's

A promising Alzheimer's drug is now getting fast-tracked by the FDA. Dr. Paul E. Schulz, the leading neurologist with UTHealth Houston and the McGovern School of Medicine, explains the benefits of Leqembi.

Latest Videos

Houston's Morning Show

View More
View More